First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital

Lancet. 1998 Apr 18;351(9110):1212. doi: 10.1016/s0140-6736(05)79166-2.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / therapeutic use*
  • Child, Preschool
  • Female
  • Humans
  • Methicillin Resistance*
  • Microbial Sensitivity Tests
  • Opportunistic Infections / drug therapy*
  • Sepsis / drug therapy*
  • Sepsis / microbiology
  • Staphylococcal Infections / drug therapy*
  • Staphylococcal Infections / microbiology
  • Staphylococcus aureus / drug effects*
  • Vancomycin / adverse effects
  • Vancomycin / therapeutic use*

Substances

  • Anti-Bacterial Agents
  • Vancomycin